J&J Creates LTL to Shield Talc Liability
Johnson & Johnson used a Texas Two-Step maneuver to transfer talc liabilities to LTL Management, which filed for bankruptcy in October 2021.
Johnson & Johnson announced in October 2021 that it had created a new subsidiary called LTL Management LLC to hold all liabilities related to talc-based products. The subsidiary immediately filed for Chapter 11 bankruptcy protection in North Carolina, halting approximately 38,000 pending lawsuits.
A Controversial Legal Strategy
The maneuver employed a legal technique known as the Texas Two-Step, which allows corporations to use Texas’s divisive merger laws to separate assets from liabilities. Under this approach:
- A company undergoes a divisive merger under Texas law, splitting into two entities
- One entity retains the valuable operating assets
- The other entity (in this case, LTL Management) receives the liabilities
- The liability-holding entity files for bankruptcy
Johnson & Johnson, one of the world’s most valuable corporations with a market capitalization exceeding $400 billion, transferred an estimated $2 billion to LTL to fund potential settlements. The parent company remained solvent and continued normal operations.
Why North Carolina?
LTL Management filed its bankruptcy petition in Charlotte, North Carolina, rather than New Jersey where J&J is headquartered. Legal observers noted that North Carolina’s bankruptcy courts had been viewed as more favorable to corporate debtors.
The case was later transferred to New Jersey following objections from plaintiffs’ attorneys who argued the filing location was chosen for strategic advantage rather than legitimate business reasons.
Plaintiff Reaction
Attorneys representing talc claimants condemned the move as an abuse of the bankruptcy system. The strategy effectively froze all pending lawsuits while the bankruptcy court took control of the claims resolution process.
“This is a solvent company trying to use bankruptcy to avoid accountability,” said one plaintiffs’ attorney quoted in news reports at the time. “Bankruptcy is supposed to be for companies that cannot pay their debts, not for companies that simply don’t want to.”
The tactic prevented cases from going to trial, where juries had previously returned multibillion-dollar verdicts against J&J in talc-related lawsuits.
The Claims at Issue
The lawsuits consolidated under the bankruptcy involved allegations that Johnson & Johnson’s talc-based baby powder was contaminated with asbestos and caused cancer. Claims fell into two primary categories:
Ovarian cancer claims: Women who used talc powder for feminine hygiene alleged that the product caused ovarian cancer. These claims represented the majority of cases.
Mesothelioma claims: A smaller number of claimants alleged that asbestos contamination in talc products caused mesothelioma. These cases were often excluded from bankruptcy settlement proposals due to their different nature and the strength of causation evidence.
J&J’s Position
Johnson & Johnson maintained that its talc products were safe and did not contain asbestos. The company characterized the bankruptcy filing as an effort to efficiently resolve claims rather than fight them case by case.
“We continue to believe our products are safe, do not contain asbestos, and do not cause cancer,” the company stated in announcing the bankruptcy filing. “This action is consistent with our effort to resolve all remaining talc litigation in a fair and efficient manner.”
Setting a Precedent
The J&J bankruptcy became a test case for whether the Texas Two-Step strategy would survive legal challenges. Consumer advocates, bankruptcy scholars, and some lawmakers warned that allowing wealthy corporations to use this tactic would undermine the bankruptcy system and deny claimants their day in court.
The case attracted attention from Congress, with some legislators calling for reforms to prevent abuse of bankruptcy by solvent companies facing mass tort litigation.
J&J’s Texas Two-Step bankruptcy strategy was dismissed by the Third Circuit Court of Appeals in 2023 as filed in bad faith. The company attempted the maneuver two more times before abandoning the approach in 2025. Individual lawsuits have since resumed and resulted in massive verdicts.
What Followed
LTL Management’s first bankruptcy would ultimately be dismissed in 2023 when the Third Circuit Court of Appeals ruled that the filing was made in bad faith. J&J would attempt the strategy two more times before finally abandoning the bankruptcy approach in 2025.
References
Reuters. J&J spin-off LTL Management to file bankruptcy to protect talc liabilities.
https://www.reuters.com/business/healthcare-pharmaceuticals/jj-spin-off-ltl-management-file-bankruptcy-protect-talc-liabilities-2021-10-14/
The New York Times. Johnson & Johnson Uses Bankruptcy to Corral Talc Lawsuits.
https://www.nytimes.com/2021/10/14/business/johnson-johnson-bankruptcy-talc.html
Reader Q&A
Frequently Asked Questions
What is the Texas Two-Step bankruptcy?
A legal maneuver using Texas’s divisive merger laws to separate assets from liabilities. A company splits into two entities. One keeps valuable operating assets, the other receives liabilities and files bankruptcy. This allows solvent companies to use bankruptcy protection to halt lawsuits.
Why was this controversial?
Critics argued it abused bankruptcy law, which is designed for companies that cannot pay debts. Not companies that simply don’t want to. J&J had a market cap exceeding $400 billion while using bankruptcy to freeze 38,000 lawsuits. The strategy prevented cases from going to trial where juries had awarded billions.
What happened to LTL Management's bankruptcy?
The Third Circuit Court of Appeals dismissed it in 2023, ruling the filing was made in bad faith. J&J tried the strategy two more times before abandoning it in 2025. Individual lawsuits have since resumed, resulting in massive verdicts including the $1.56 billion Craft verdict in December 2025.
Could people with mesothelioma still sue during the bankruptcy?
The bankruptcy filing froze pending lawsuits and transferred claims to bankruptcy court. However, mesothelioma cases were often excluded from bankruptcy settlement proposals due to their different nature and strong causation evidence. After the bankruptcy was dismissed, individual lawsuits resumed.
What is the average settlement for asbestos exposure?
Settlement amounts for asbestos exposure vary significantly based on diagnosis. People with mesothelioma typically receive pre-trial settlements ranging from $1 million to $2.4 million, while those with asbestos-related lung cancer average $250,000 to $400,000. Non-malignant asbestos-related conditions like asbestosis generally settle for $10,000 to $50,000, though trust fund payouts for these conditions average $300,000 to $400,000 across all trusts. Trial verdicts are substantially higher, with mesothelioma cases averaging around $9 million when they reach jury verdict. Settlement amounts depend on factors including diagnosis certainty, strength of exposure evidence, number of liable defendants, and case jurisdiction.
Does everyone with mesothelioma get a settlement?
No, not everyone with mesothelioma receives a settlement. Eligibility requires evidence of asbestos exposure, such as work history or military records, and a confirmed diagnosis, with claims subject to state statutes of limitations typically 1-3 years after diagnosis or death. Over 99% of filed mesothelioma lawsuits settle for $1-1.4 million on average, but cases may go to trial or fail without proven liability. Family members or estate representatives of deceased people with mesothelioma may also pursue wrongful death claims if exposure links are established. Asbestos trust fund claims offer another compensation avenue without always requiring a lawsuit.
How much money is left in the mesothelioma trust fund?
Estimates place more than $30 billion in assets across over 60 active mesothelioma asbestos trust funds as of 2026. This figure reflects assets available after more than $17 billion in prior payouts. People with mesothelioma typically receive total compensation of $300,000 to $400,000 across claims filed with multiple trusts. Individual trust payouts vary from $7,000 to $1.2 million based on scheduled values and payment percentages.
What is the average claim for asbestosis?
Typical settlements for asbestosis and other non-malignant asbestos-related conditions range from $10,000 to $50,000, with trust fund payouts often $2,500 to $7,500 for mild cases and up to $100,000 for severe impairment. Average non-malignant payouts frequently fall under $50,000 or as low as $1,000 to $10,000 for lower-severity claims. These amounts reflect data from resolved claims, where non-malignant cases receive about one-tenth the compensation of malignant claims like mesothelioma.